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Abstract HIV/AIDS stigma is a common thread in the
narratives of pregnant women affected by HIV/AIDS
globally and may be associated with refusal of HIV testing.
We conducted a cross-sectional study of women attending
antenatal clinics in Kenya (N = 1525). Women completed
an interview with measures of HIV/AIDS stigma and
subsequently information on their acceptance of HIV
testing was obtained from medical records. Associations of
stigma measures with HIV testing refusal were examined
using multivariate logistic regression. Rates of anticipated
HIV/AIDS stigma were high—32% anticipated break-up of
their relationship, and 45% anticipated losing their friends.
Women who anticipated male partner stigma were more
than twice as likely to refuse HIV testing, after adjusting
for other individual-level predictors (OR = 2.10, 95% CI:
1.15–3.85). This study demonstrated quantitatively that
anticipations of HIV/AIDS stigma can be barriers to
acceptance of HIV testing by pregnant women and high-
lights the need to develop interventions that address preg-
nant women’s fears of HIV/AIDS stigma and violence
from male partners.
Keywords HIV/AIDS  Stigma  Pregnancy  Kenya 
Intimate partner violence
Introduction
In sub-Saharan Africa, women comprise approximately
60% of adults living with HIV [1] and there is evidence
that pregnant women have a higher risk of acquiring HIV
infection than non-pregnant women [2, 3]. Vertical trans-
mission of HIV from mother-to-child remains a signiﬁcant
problem in the region; UNAIDS estimates that 390,000
children in sub-Saharan Africa were newly infected with
HIV in 2008—around 90% of the global burden of new
pediatric infections [4]. This situation persists despite the
fact that antenatal HIV testing and prevention of mother-to-
child-transmission (PMTCT) interventions can reduce
vertical transmission of HIV to as low as 1–2% [5]. In
many countries, HIV testing is now routinely included in
antenatal care (ANC) services, unless the pregnant woman
explicitly refuses it [6, 7]. The promise of antenatal HIV
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DOI 10.1007/s10461-010-9798-5testing and PMTCT programs has led UNAIDS to call for a
‘‘virtual elimination’’ of mother-to-child transmission of
HIV by 2015 [1]. However, several challenges remain to
achieving successful implementation and scale-up of these
services. Although ANC services are visited by the
majority of pregnant women at least once during preg-
nancy, in 2008 only 28% of pregnant women in sub-Sah-
aran Africa received an HIV test [1].
HIV/AIDS stigma is a common thread in the narratives
of pregnant women affected by HIV/AIDS globally [8, 9].
Because a pregnant woman is often the ﬁrst family member
to be tested for HIV, she may be blamed for bringing the
virus into the family and may suffer from adverse conse-
quences of her HIV-positive status disclosure. Fears and
experiences of stigma or discrimination from health work-
ers, male partners, family, and community members have
been identiﬁed as potential explanations for the facts that
some pregnant women avoid maternity services altogether
[10, 11], refuse antenatal HIV testing [12–14], or drop out
of PMTCT programs once enrolled [15]. Theoretical
frameworks and research on HIV/AIDS stigma also indicate
that different dimensions of stigma—including anticipated
stigma, perceived community stigma, enacted stigma, and
self-stigma—adversely affect quality of life, healthcare
access, and health outcomes [16–18]. Despite the consensus
that HIV/AIDS stigma plays a signiﬁcant role in deterring
pregnant women from utilizing HIV services, few studies
have attempted to quantitatively assess how these different
dimensions of stigma affect uptake of HIV testing among
pregnant women in high HIV prevalence settings.
Understanding women’s reasons for HIV test refusal is
crucial for the development of interventions to increase
antenatal HIV testing and extend the coverage of HIV
services for pregnant women and their infants. We used
data from the Maternity in Migori and AIDS Stigma Study
(MAMAS Study) to examine how pregnant women’s per-
ceptions of HIV/AIDS stigma inﬂuenced HIV testing
uptake at ANC clinics in Nyanza Province, Kenya. Nyanza
Province has the highest HIV prevalence in Kenya, with
approximately 15% of adults 15–49 years of age testing
HIV-positive [19]. Prevalence among pregnant women
attending ANC clinics is higher, at an estimated 18%
within districts included in this study (Family AIDS Care
and Education Services program data [20]). In this manu-
script we aim to a) describe the extent to which pregnant
women who do not yet know their current HIV status
perceive and fear HIV/AIDS stigma, and b) examine the
relationships of quantitative measures of HIV/AIDS stigma
to pregnant women’s refusal of HIV testing. In particular,
we feel that it is important both theoretically and practi-
cally to understand the relative importance of different
dimensions and sources of HIV/AIDS stigma—especially
fears of stigma and negative consequences for self
(anticipated stigma) versus general perceptions of stigma
in the community (perceived community stigma)—for
pregnant women’s uptake of HIV services.
Methods
The MAMAS Study
The MAMAS Study is a longitudinal study of pregnant
womenattendingnineruralANCclinicsinNyanzaProvince
that aims to examine the effects of HIV/AIDS stigma on
pregnant women’s use of health services. The study sites
weregovernmenthealthfacilities(foursub-districthospitals
and ﬁve health centers/dispensaries), all receiving support
from the President’s Emergency Plan for AIDS Relief-fun-
dedFamilyAIDSCareandEducationServices(FACES)for
HIV prevention, care, and treatment efforts. All the sites
were also part of an on-going cluster randomized trial of the
integration of HIV services into ANC clinics (Clinicaltri-
als.gov # NCT00931216). This study received ethical
approval from the Kenya Medical Research Institute Ethical
Review Committee and the Committee on Human Research
of the University of California, San Francisco.
Pregnant women who did not know their current HIV
status (never tested or tested negative more than 3 months
ago) were recruited for the MAMAS Study, taken through
a signed informed consent process, and interviewed just
before their ANC visit by a trained interviewer using a
questionnaire programmed on a small handheld computer
(PDA). Additional inclusion criteria included the visit
being her ﬁrst ANC attendance for this pregnancy, being
18 years of age or older, and being at a gestational age of
28 weeks or less. Subsequently, all pregnant women were
routinely offered voluntary HIV counseling and testing as
part of the ANC visit (rapid testing) and, if they consented,
information on their acceptance of HIV testing and their
HIV serostatus were obtained from their medical records
after their ANC visit. Recruitment and baseline interviews
for the MAMAS Study took place between November 2007
and April 2009, although study activities were interrupted
temporarily during the post-election period (January–
March 2008). The current analyses use data from the
baseline interviews of this longitudinal study.
Measures
Stigma and Discrimination Scales
HIV/AIDS stigma was measured using multi-item scales
that have been developed and demonstrated to be valid and
reliable in sub-Saharan African settings, as described
below. These stigma scales were given to those participants
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according to a preceding question.
‘‘Anticipated stigma’’ refers to the anticipation that one
will personally experience speciﬁc types of stigma or dis-
criminationifoneisfoundtobeHIV-positiveandone’sHIV-
positive status is disclosed to others. A 9-item scale for
measuring this construct was developed and tested in a study
in Botswana [21]. In the scale items, a respondent is asked,
‘‘Do you think any of the following things might happen to
you, if you were to test positive for HIV and others found out
about your HIV status?’’ Items include losing friends, being
treated like an outcast by the community, being treated badly
at work or school, experiencing break-up of marriage or
relationship,sufferingfromphysicalabusebyspouse/partner,
losing one’s job/livelihood, being treated badly by health
professionals, and/or being disowned or neglected by family.
Foreachitem,participants indicatedwhether theyanticipated
theeventornot(Y/Nresponse,coded1/0).Atotalanticipated
stigma score was created by taking the mean of the responses
for the 9 items, for women who had non-missing data for at
least6oftheitems.Reliabilityofthis total score was foundto
be high in our sample (Cronbach’s a = 0.86) and a factor
analysis revealed one underlying factor (data not shown).
Variables were also created to examine anticipated stigma by
source; we created dichotomous measures of anticipated
stigma from the male partner (answered yes to either or both
of the male partner items), from family members (answered
yes to either or both of the family items), and from others
(answered yes to one or more of the items regarding others).
In contrast, we also measured women’s general attitudes
and perceptions about persons living with HIV/AIDS
(PLWHA) and how PLWHA are treated in the community,
and we refer to this as ‘‘perceived community stigma’’. We
used the stigma scale developed by National Institute of
MentalHealthProjectAccepttomeasurethisconstruct[22].
The scale consists of 22 items, such as, ‘‘People who have
HIV/AIDS are cursed’’ and ‘‘People living with HIV/AIDS
in this community face ejection from their homes by their
families’’. Participants were asked to rate these statements
on a 4-point Likert scale from strongly agree to strongly
disagree. The scale assesses three dimensions: negative
attitudes and beliefs associated with PLWHA (negative
attitudes, 8 items), perceptions of acts of discrimination
faced by PLWHA within the community (discrimination, 7
items), and attitudes and beliefs related to fair treatment of
PLWHA (equity, 4 items). The scale was previously tested
inTanzania,Zimbabwe,SouthAfrica,andThailand,andthe
three sub-scales were found to have acceptable reliability
[23]. Following the example of the scale developers, mean
sub-scale scores were computed for women who had no
more than one missing item in that sub-scale, and the mean
totalscorewascomputedonlyforthosewhohadvalidscores
on all three sub-scales. Scores on the scales ranged from 0
(stronglyagree)to3(stronglydisagree);withnegativeitems
reverse-coded so that higher scores indicated higher per-
ceptions of HIV/AIDS stigma. In our sample, reliability of
the total stigma score, the negative attitudes sub-scale, the
discrimination sub-scale, and the equity sub-scale were
found to be 0.85, 0.78, 0.75, and 0.70, respectively (Cron-
bach’s a). Due to the relatively low reliability of the equity
sub-scale, we did not use it in further analyses, similar to the
approach of the scale’s authors [23].
Refusal of HIV Testing
Data on the women’s HIV testing uptake were obtained
from clinic records after the woman’s ANC visit was
completed. The woman’s situation was categorized as: (1)
accepted testing, (2) refused testing, or (3) no HIV testing
service available. For analyses with refusal of HIV testing
as the outcome, only women who were actually offered
HIV testing (HIV testing service was available at the
facility on the day of their ﬁrst ANC visit) were included.
Other Predictors of HIV Testing Refusal
Other individual-level variables examined (due to their
associations with HIV testing refusal in theory or the lit-
erature) included the woman’s socio-demographic charac-
teristics (age, education, gestational age, religion, marital
status, polygamous relationship, occupation, and ethnicity),
her knowledge of mother-to-child transmission, her know-
ing someone with HIV/AIDS, and her knowledge of hus-
band’s/male partner’s HIV testing status. Knowledge of
mother-to-child transmission and knowing someone with
HIV/AIDS were hypothesized to be positively associated
with HIV testing uptake, since women would be aware of
the potential risks of HIV transmission and beneﬁts of
testing. Not knowing if the male partner had been tested for
HIV was hypothesized to be negatively related to HIV test
uptake, as an indicator of lack of couple communication on
this issue, which has been shown to negatively affect
women’s willingness to accept an HIV test [24]. Other
variables included in the analyses were site (health facility
where the woman was recruited and interviewed) and tim-
ing (months between study start date and interview date).
Analytic Methods
Psychometric properties of the HIV/AIDS stigma measures
were assessed by calculating reliability (Cronbach’s a) for
the total and sub-scales, and conducting factor analysis.
Next, associations of stigma measures and other predictor
variables with HIV testing refusal were examined by cal-
culating unadjusted ORs and 95% CIs, while accounting
for clustering by site (health facility). In order to be able to
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for clustering by site, we then ran a random effects mul-
tivariate logistic regression model [25] with site modeled
as a random effect, including different HIV/AIDS stigma
measures, as well as other individual-level predictors that
had signiﬁcance levels \0.05 in univariate analysis.
Analyses were conducted with SPSS Statistics 17.0 and
Intercooled Stata 9.0.
Results
The refusal rate among women approached to participate in
the study was 3.3% (67 women) and of those who enrolled
in the study only nine women subsequently withdrew.
Fig. 1 shows the ﬂow diagram for inclusion in the current
analyses. The sample for our analyses of HIV/AIDS stigma
and HIV test refusal includes 1525 women (86% of all
women interviewed). The women in this group did not
signiﬁcantly differ from those not included (252) in terms
of age, education, religion, marital status, ethnicity, months
of pregnancy, or parity (data not shown).
Characteristics of Participants
Table 1 presents the characteristics of pregnant women
from the nine rural ANC clinics included in the current
analysis (n = 1525). As reﬂected in the table, the majority
of the participants were relatively young women (mean
23.6 years, SD = 5.4) of low socio-economic status (only
16% had more than a primary school education), Catholic
or Seventh Day Adventist (52.2%), and of the dominant
ethnic group in the study districts (92% were from the Luo
ethnic group). Twenty-one percent of the women were
experiencing their ﬁrst pregnancy, while 36.3% had three
or more previous pregnancies.
HIV/AIDS Stigma
Tables 2 and 3 show levels of anticipated stigma and per-
ceived community stigma for the women included in the
present analyses. Rates of anticipatedstigmaassociated with
disclosure of HIV-positive status were very high—for
example, 28% of women feared rejection by their family,
32%anticipatedbreak-upoftheirrelationshipwiththeirmale
partner, and 45% anticipated that they would lose their
friends.Comparisonoftotalanticipatedstigmaandperceived
community stigma scores for women interviewed in the ﬁrst
10 monthsof thestudy(approximately half thesample)with
those interviewed later revealed that mean stigma scores
were signiﬁcantly higher in the earlier period (anticipated
stigma: 0.2981 vs. 0.2676, t = 1.97, P = 0.049; perceived
communitystigma:0.9133vs.0.7803,t = 6.79,P\0.001).
HIV Test Refusal and Test Results
For those women who were offered HIV testing, refusal of
an HIV test ranged from 16% in the early months of the
study (March–May 2008), to 2% towards the end of the
study (December 2008–February 2009), for an overall
refusal rate of 6% for the entire study period. This trend in
increasing acceptance of HIV testing by pregnant women
at the study sites is also reﬂected in FACES program data
for the districts (not shown). Of those study participants
who accepted testing, 18% tested HIV-positive.
Predictors of HIV Test Refusal
Table 4 shows the associations of socio-demographic vari-
ables and other potential individual-level predictors with
HIV test refusal, accounting for clustering by site. As can be
seen in the table none of the socio-demographic character-
istics examined were signiﬁcantly associated with HIV test
refusal. The woman’s lack of knowledge about her male
partner’sHIVtestingstatusandhernotknowinganyonewith
HIV/AIDS were signiﬁcantly and positively associated with
Fig. 1 Flow diagram for inclusion in analyses of stigma and HIV test
refusal
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characteristics of MAMAS
study participants included in
the analysis (N = 1525)
Age, n (%)
B20 579 (38.0)
21–30 767 (50.3)
C31 179 (11.7)
Education, n (%)
Only primary school (elementary) or less 1277 (83.7)
Secondary school (high school) or more 248 (16.3)
Reading literacy, n (%)
Easily 664 (43.5)
With difﬁculty 616 (40.4)
Not at all 245 (16.1)
Religion, n (%)
Roman Catholic 287 (18.8)
Seventh Day Adventist 509 (33.4)
Other 728 (47.8)
Ethnicity, n (%)
Luo 1407 (92.3)
Other 118 (7.7)
Household goods, n (%)
Refrigerator 16 (1.0)
Electricity 56 (3.7)
Television 159 (10.4)
Mobile phone 723 (47.4)
Radio 1149 (75.3)
Occupation, n (%)
Housework 323 (21.2)
Selling things/ﬁsh monger 329 (21.6)
Farming/agricultural work/manual labor 772 (47.5)
Other 147 (9.7)
Marital status, n (%)
Not currently married 188 (12.3)
Currently married 1336 (87.7)
Currently living with male partner, n (%)
Yes 1331 (87.3)
No 193 (12.7)
Male partner has other wives (n = 1331 women currently living
with a male partner), n (%)
Yes 394 (29.6)
No 937 (70.4)
Male partner’s occupation (n = 1330), n (%)
Selling things 142 (10.7)
Farming/agricultural work 508 (38.2)
Fishing 161 (12.1)
Manual labor 205 (15.4)
Other type of job 314 (23.6)
Mean months of pregnancy at time of ﬁrst ANC visit (woman’s report)
(median, range)
5.1 (5, 0.4–9.0)
Mean number of pregnancies (median, range) 3.2 (3, 1–16)
Mean number of live births (median, range) 2.2 (2, 0–15)
Mean number of living children (median, range) 1.8 (2, 0–10)
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closertothestudystartdateweresigniﬁcantlymorelikelyto
refuse HIV testing. The overall anticipated stigma score, as
well as the combined measure of anticipated male partner
stigma, were strongly associated with HIV test refusal,
whereasneitherthecombinedmeasuresofanticipatedstigma
from family or others, nor any of the perceived community
stigma total or sub-scales were signiﬁcantly associated with
HIV test refusal. Looking individually at the anticipated
stigma items, those that were signiﬁcantly associated with
HIV test refusal were anticipations of break-up of relation-
ship with partner (OR = 1.84, 95% CI: 1.19–2.85, P =
0.006), physical abuse from partner (OR = 1.65, 95% CI:
1.04–2.61, P = 0.032), neglect by family (OR = 1.74, 95%
CI: 1.13–2.68, P = 0.013), bad treatment by health workers
(OR = 2.12, 95% CI: 1.2–3.69, P = 0.008), and losing job
or livelihood (OR = 1.74, 95% CI: 1.10–2.73, P = 0.017).
Multivariate Analysis of HIV/AIDS Stigma and Other
Predictors on HIV Test Refusal
For multivariate analysis we used random effects logistic
regression, with all estimates adjusted for months since
study start, and accounting for clustering by site (health
facility). In this adjusted model, anticipated stigma from
the male partner remained strongly associated with HIV
test refusal (OR = 2.10, 95% CI: 1.15–3.85, P = 0.016),
after adjustment for all the other variables in the model
(Table 5). The other signiﬁcant predictors from univariate
analysis also retained their signiﬁcant independent associ-
ations with test refusal after adjustment—those who knew
someone with HIV/AIDS were less likely to refuse HIV
testing (OR = 0.52, 95% CI: 0.31–0.89, P = 0.016), and
those with lack of knowledge of their male partner’s HIV
testing status were almost twice as likely to refuse testing
(OR = 1.77, 95% CI: 1.05–2.99, P = 0.033). Measures of
anticipated family stigma, anticipated stigma from others,
and perceived community stigma were not signiﬁcantly
associated with the outcome in this model.
Discussion
Among women interviewed at their ﬁrst antenatal clinic
visit of the index pregnancy in selected government health
facilities in Nyanza Province, Kenya, anticipated HIV/
Table 2 Anticipated HIV/
AIDS stigma (N = 1525)
a 46 Women (3.0%) refused to
answer this question
b 65 Women (4.3%) refused to
answer this question
Anticipated HIV/AIDS stigma item: Do you think any of the following
things might happen to you, if you were to test positive for HIV
and others found out about your HIV status? Do you think you would…?
Women responding
‘‘yes’’
n (%)
1. Be treated badly by health workers (O) 152 (10.0)
2. Lose your job/livelihood (O) 336 (22.0)
3. Be denied care by family if sick (F) 371 (24.3)
4. Be rejected by family (F) 432 (28.3)
5. Be treated badly at work or school (O) 466 (30.6)
6. Be physically abused by your partner (P)
a 391 (25.6)
7. Experience break-up of your relationship (P)
b 489 (32.1)
8. Become a social outcast (O) 513 (33.6)
9. Lose your friends (O) 688 (45.1)
Anticipated any stigma from male partner (P) (items 6 and/or 7) 569 (37.3)
Anticipated any stigma from family (F) (items 3 and/or 4) 563 (36.9)
Anticipated any stigma from others (O) (items 1,2,5,8, and/or 9) 941 (61.7)
Mean combined anticipated stigma score (median, range) 0.28 (0.22, 0–1)
Table 3 Perceived community stigma scale and sub-scales
Scale or sub-scale Number
of items
Number of women
with complete data
Mean Median Range (maximum
possible score of 3)
Cronbach’s
alpha
Total 18 1504 0.85 0.89 0–2.39 0.85
Negative attitudes 7 1515 0.79 0.86 0–2.86 0.78
Perceived discrimination 7 1509 0.90 1.00 0–3.00 0.75
Equity 4 1523 0.89 1.00 0–3.00 0.70
Sub-scales were constructed as in Genberg et al. [23], after excluding one additional item, ‘‘People with HIV/AIDS should not have the same
freedoms as everyone else’’. This item was dropped from the Total and Equity scales, due to very low correlation with the other scale items in
this sample
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of the partner’s HIV status were found to be the main
factors associated with refusal of HIV testing. We also
found that women were more likely to accept HIV testing if
they knew someone who was HIV-positive.
This study demonstrated that anticipated stigma regard-
ing HIV/AIDS stigma can be a barrier to acceptance of HIV
testing by pregnant women, even in an environment where
HIV testing in the antenatal clinic is becoming the norm.
Although refusal of HIV testing at the health facilities par-
ticipating in this study declined from a high of 16% to only
2% of women by the end of the study, we would argue that
even a small percentage of women refusing HIV testing is
important in this high HIV prevalence setting. In a location
where almost one in every ﬁve pregnant women is HIV-
positive, every woman who refuses HIV testing represents
an important missed chance to prevent mother-to-child
transmission and promote maternal and child health. In
many othersettingsin Kenya and other sub-Saharan African
countries, high rates of refusal of HIV testing by pregnant
women continue to be seen, and it is likely that HIV/AIDS
stigma plays a role in these settings as well [14, 26].
We found that a woman’s speciﬁc fears of stigma and
negative events for herself after an HIV-positive test result
Table 4 Associations of predictor variables with HIV test refusal (Unadjusted) (N = 1525)
Variable HIV test refusers
(N = 94)
n (%)
b
HIV test acceptors
(N = 1431)
n (%)
b
OR for
refusal
a
95% CI P value
Socio-demographic characteristics
Mean age 23.9 23.6 1.02 0.98–1.07 0.323
Low education (only primary or less education) 77 (81.9) 1200 (83.9) 0.73 0.40–1.33 0.307
Currently married 80 (86.0) 1256 (87.8) 1.01 0.53–1.94 0.966
In a polygamous relationship 23 (24.7) 371 (25.9) 0.88 0.52–1.48 0.639
First pregnancy 17 (18.1) 309 (21.6) 0.89 0.50–1.58 0.699
Working in farming or manual labor
c 32 (34.4) 690 (48.3) 1.12 0.69–1.83 0.635
Luo ethnic group 91 (96.8) 1316 (92.0) 2.65 0.78–8.87 0.117
HIV/AIDS stigma measures
Anticipated stigma
Anticipated stigma from partner
d 47 (50.0) 522 (36.5) 2.07 1.29–3.33 0.002
Anticipated stigma from family
e 45 (47.9) 518 (36.2) 1.53 0.96–2.42 0.074
Anticipated stigma from others
f 61 (64.9) 880 (61.5) 1.45 0.90–2.32 0.129
Mean anticipated stigma combined score (n = 1511)
g 0.3499 0.2805 2.13 1.06–4.28 0.035
Perceived community stigma
Mean negative attitudes sub-scale (n = 1515) 0.8346 0.7878 1.21 0.70–2.09 0.504
Mean perceived discrimination sub-scale (n = 1509) 0.8784 0.8967 0.86 0.47–1.56 0.614
Mean total perceived community stigma score (n = 1504)
h 0.8414 0.8540 0.92 0.45–1.85 0.808
Other individual-level predictors
Mean months since the study began (Nov 20, 2007) 8.99 10.66 0.91 0.86–0.97 0.003
Knowledge of mother-to-child transmission 74 (81.3) 1256 (88.5) 0.81 0.44–1.49 0.504
Knows someone with HIV/AIDS 63 (67.0) 1109 (77.6) 0.44 0.27–0.73 0.001
Does not know if partner has tested for HIV
i 31 (33.0) 308 (21.5) 1.95 1.19–3.20 0.008
a Estimates account for clustering by site (health facility), using random effects logistic regression
b Results are presented as n(%) in these columns, unless otherwise indicated to be means. The denominators for percentages differ slightly in
some cases, due to small numbers of missing responses
c As compared to those working in housework, selling things (including ﬁsh), or other occupations (combined)
d 72 Women refused to answer one or both of the anticipated partner stigma items
e 35 Women refused to answer one or both of the anticipated family stigma items
f 26 Women refused to answer one or both of the anticipated ‘‘other’’ stigma items
g Mean anticipated stigma score was computed for women who had non-missing data for at least 6 of the 9 items
h Mean perceived community stigma sub-scale scores were computed for women who had no more than one missing item in that sub-scale, and
the mean total score was computed for those who do not have more than 1 item missing on any sub-scale
i 22 Women refused to answer the question about her knowledge of her male partner’s HIV testing status
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important than her general perceptions of HIV/AIDS
stigma experienced by PLWHA in the community. This
corresponds with the psychological literature on stigma
that suggests that anticipations of personal experiences of
stigma and discrimination are stronger motivators of
behavior than general perceptions of what happens to
‘‘other people’’ [27]. In addition, among the anticipated
stigma items, we found that fears of stigma and discrimi-
nation from male partners were more important negative
inﬂuences on HIV test acceptance than fears of stigma and
discrimination from others (friends, family, co-workers,
health workers, others in the community, etc.). Male part-
ners can often have the biggest direct impact on the
woman’s life and thus it is not surprising that fears about
negative reactions from these inﬂuential close persons
would be most predictive. Studies in other settings have
also found stigma from partners and family to be inﬂuential
[28]. Another important point is that HIV-positive pregnant
women often appear healthy and do not disclose their HIV
status [29]. Thus, their HIV status is not apparent to others
and fears of stigma and discrimination from people in the
wider community may be less salient.
We found that fears of negative male partner reactions
(fear of domestic violence and rejection by one’s partner)
and lack of knowledge about male partner HIV testing
were the most important inﬂuences on women’s decision
regarding HIV testing, in line with results from other East
African settings [12, 13, 30]. While our analyses suggest
that general perceptions of stigma related to HIV/AIDS
may be declining over time in this population, it seems that
gender norms and relations, as well as power dynamics
within male–female relationships, are slower to change. An
HIV-infected woman may face stigma from her male
partner because he perceives that HIV/AIDS infection
means that she has been promiscuous—thus violating the
gender norm of female sexual faithfulness to a single male
partner [31]. These perceptions lead to conﬂict in the
couple, often resulting in negative consequences for the
woman (such as rejection, abandonment, and/or violence).
These ﬁndings suggest that efforts need to be strength-
ened to encourage men to engage in a constructive way in
their partner’s antenatal care, including HIV counseling
and testing, in rural Kenya [24]. As in other similar set-
tings, pregnant women often see partner consent and
approval as an important condition for HIV testing
acceptance [32, 33]. Solutions such as couple counseling
and testing with facilitated disclosure [34], or if not pos-
sible, equipping women with skills for safe disclosure and
partner communication about HIV/AIDS, need to be
explored.
Although this study did not speciﬁcally examine reasons
for the observed decrease in HIV testing refusal, we know
that great emphasis was placed on encouraging HIV testing
of pregnant women in Kenya during the study period.
When the study began in 2007, the Migori and Rongo
Table 5 Multivariate logistic
regression of HIV/AIDS stigma
measures and other signiﬁcant
individual-level predictor
variables on HIV test refusal
(n = 1503)
a
a N is less than 1525 due to
small numbers of missing
values on individual variables
b All estimates adjusted for
time since the study began
(categorical variable in 3-month
chunks) and the other variables
in the table. Estimates also
account for clustering by site
(health facility) as a random
effect
c Reference category
Variable Number of women
in the category (n)
Adjusted OR for
HIV test refusal
b
95% CI P value
Knowing someone with HIV/AIDS
Doesn’t know anyone
c 349
Knows someone 1154 0.52 0.31–0.89 0.016
Knowledge of male partner HIV testing
Knows whether or not he tested
c 1152
Doesn’t know whether or not he tested 331 1.77 1.05–2.99 0.033
Refused to answer 20 2.45 0.64–9.35 0.191
Anticipated stigma from male partner
No
c 879
Yes 565 2.10 1.15–3.85 0.016
Refused to answer 59 1.99 0.65–6.07 0.229
Anticipated stigma from family members
No
c 919
Yes 558 1.02 0.54–1.92 0.954
Refused to answer 26 1.04 0.20–5.49 0.960
Anticipated stigma from others
No
c 551
Yes 933 1.03 0.55–1.93 0.924
Refused to answer 19 1.14 0.16–8.21 0.895
Total perceived community stigma score 1503 0.62 0.28–1.39 0.247
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123District Ministry of Health teams had newly begun their
cooperation with FACES, with a mandate to strengthen
PMTCT services. During the study period, the participating
health facilities were strengthened through training, mobile
team visits, and the employment of lay health workers and
volunteers through FACES. Thus, the same trend of
increasing HIV test acceptance was seen across the 60
clinics supported by FACES in these two districts. Despite
the persistence of many barriers (including HIV/AIDS
stigma), it appears that well trained and supported health
workers are able to convince most pregnant women to
accept HIV testing in this setting. A recent analysis of data
on HIV test acceptance at ANC clinics in Kenya found that
site factors were more important than participant factors in
predicting HIV test acceptance among pregnant women
[35].
The current study has some limitations. First, the study
only included pregnant women who had at least one ANC
visit and came for their ﬁrst visit within the ﬁrst 28 weeks
of pregnancy. It is possible that women in the community
who come for their ﬁrst ANC visit later in pregnancy or
who do not come for ANC at all may be most affected by
HIV/AIDS stigma. Thus, our study may underestimate the
effects of HIV/AIDS stigma on HIV test refusal. We are
currently collecting community-based qualitative data to
explore this issue further. In addition, our results may be
subject to social desirability bias. Data on HIV/AIDS
stigma were collected through face-to-face interviews,
which may have resulted in underreporting.
Although it appears that HIV testing refusal may have
declined in this setting, along with some reductions in HIV/
AIDS stigma, the next important challenge for the future is
what happens after an HIV-positive test result. In most sub-
Saharan Africa settings, less than half of HIV-positive
women receive PMTCT interventions and even fewer of
these women enroll in HIV care and treatment for their
own health [1]. Successful perinatal prevention of HIV
requires women to navigate a cascade of events that begins
with offering HIV testing and continues through enrollment
in care and adherence to the prescribed antiretroviral reg-
imen [36]. Even when women do accept HIV testing, high
loss to follow-up in PMTCT programs threatens the public
health potential of this model [37, 38]. Given the important
role of anticipated HIV/AIDS stigma in refusal of HIV
testing shown in this study, it will be important to examine
the role of anticipated and experienced HIV/AIDS stigma
in uptake of the services offered after HIV testing, as well
as in uptake of other maternal child health services.
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